文献速递肿瘤 PET/CT骨显像与常规 SPECT

18F-FDG PET代谢参数预测骨肉瘤与尤文肉瘤诱导化疗组织学反应:系统综述与网状Meta分析

18 F-FDG PET Metabolic Parameters for the Prediction of Histological Response to Induction Chemotherapy in Osteosarcoma and Ewing Sarcoma : A Systematic Review and Network Meta-analysis.
PubMed 文献 · Clin Nucl Med · 2024-09-25

该系统综述与网状Meta分析检索2008年1月至2024年1月电子数据库,纳入18项研究共714例骨肉瘤与尤文肉瘤患者,评估18F-FDG PET/CT代谢参数预测新辅助化疗组织学反应的能力。ΔTLG、ΔMTV和SUV比值被确定为组织学反应的优越预测指标,基线参数预测价值有限;作者认为这些参数有助于指导早期治疗决策。

要点

  • ΔTLG、ΔMTV和SUV比值是骨肉瘤与尤文肉瘤组织学反应的优越预测指标。
  • 基线代谢参数相比治疗后评估,预测价值有限。
  • SUV2和SUV比值的预测价值在不同截断阈值间保持一致。

核心结论

  • 18F-FDG PET/CT代谢参数,尤其是治疗后变化的参数,可有效预测骨肉瘤与尤文肉瘤患者的组织学反应。
  • 作者认为这些发现凸显18F-FDG PET/CT在指导早期治疗决策、增强个体化治疗方面的潜力。

研究设计与样本

  • 系统综述与网状Meta分析,遵循PRISMA-NMA和Cochrane指南。
  • 检索2008年1月至2024年1月的电子数据库,并以滚雪球法补充检索。
  • 纳入18项研究共714例患者,评估治疗前和治疗后SUV(SUV1、SUV2及SUV2/SUV1比值)、代谢肿瘤体积(MTV1、MTV2、ΔMTV)和总病灶糖酵解(TLG1、TLG2、ΔTLG)的预后价值。
  • 采用QUADAS-2评估偏倚风险,采用GRADE方法评估证据确定性。

主要发现

  • 18项研究共714例患者的Meta分析确定ΔTLG、ΔMTV和SUV比值为组织学反应的优越预测指标。
  • 这些参数反映的代谢活性变化为治疗有效性提供了有力指示。
  • 基线参数相比治疗后评估,预测价值有限。
  • Meta回归显示SUV2和SUV比值的预测价值在不同截断阈值间保持一致。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to evaluate the ability of 18 F-FDG PET/CT metabolic parameters to predict the histological response to neoadjuvant chemotherapy in patients with osteosarcoma and Ewing sarcoma. PATIENTS AND METHODS: This systematic review and network meta-analysis adhered to the PRISMA-NMA and Cochrane guidelines. Electronic databases were searched from January 2008 to January 2024; this search was supplemented by snowballing methods. The risk of bias was evaluated with QUADAS-2, and evidence certainty was assessed using the GRADE approach. The prognostic value of 18 F-FDG PET/CT parameters, including pretreatment and posttreatment SUVs (SUV1, SUV2 and the SUV2/SUV1 ratio), metabolic tumor volume (MTV1, MTV2, ΔMTV), and total lesion glycolysis (TLG1, TLG2, ΔTLG), was examined. RESULTS: The meta-analysis of 18 studies (714 patients) identified the ΔTLG, ΔMTV, and SUV ratio as superior predictors of histological response. The changes in metabolic activity, as indicated by these parameters, provided a robust indication of treatment effectiveness. Baseline parameters showed limited predictive value compared with posttreatment assessments. The study's robustness was confirmed through meta-regression, which revealed that the predictive value of the SUV2 and SUV ratio was consistent across various cutoff thresholds. CONCLUSIONS: 18 F-FDG PET/CT metabolic parameters, particularly those measuring changes posttherapy, are effective in predicting the histological response in patients with osteosarcoma and Ewing sarcoma. These findings underscore the potential of 18 F-FDG PET/CT in guiding early treatment decisions, thereby enhancing personalized therapeutic approaches.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yadgarov M, Berikashvili L, Rakova E, et al. 18 F-FDG PET Metabolic Parameters for the Prediction of Histological Response to Induction Chemotherapy in Osteosarcoma and Ewing Sarcoma : A Systematic Review and Network Meta-analysis. Clin Nucl Med. 2024. PMID: 39325490. doi:10.1097/RLU.0000000000005412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。